Ticker
IRWDCompany Name
IRONWOOD PHARMACEUTICALS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 29.94M | 9.7% | $ 308.52M |
3/31/2025 | $ 78.41M | 24.68% | $ 317.68M |
12/31/2024 | $ 103.41M | 29.43% | $ 351.41M |
9/30/2024 | $ 123.82M | 32.72% | $ 378.42M |
6/30/2024 | $ 146.36M | 36.54% | $ 400.56M |
3/31/2024 | $ 147.91M | 35.77% | $ 413.55M |
12/31/2023 | $ 183.15M | 41.37% | $ 442.74M |
9/30/2023 | $ 226.74M | 52.44% | $ 432.38M |
6/30/2023 | $ 263.36M | 61.64% | $ 427.28M |
3/31/2023 | $ 289.67M | 69.44% | $ 417.13M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Revenues
(=) FCF %
FCF % for IRONWOOD PHARMACEUTICALS INC is calculated as follows: FCF [ $ 140.43M ] / Revenues [ $ 399.14M ]
(=) FCF % [ 35.18% ]
Minimum
Jun 30, 2025
Maximum
Mar 31, 2023
Average
Median
filtered constituents | 3.18K |
---|---|
min | -58.23% |
max | 68.19% |
average | 7.85% |
median | 7.37% |
std | 19.48% |